116 related articles for article (PubMed ID: 30887054)
21. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
Dharni N; Armstrong D; Chung-Faye G; Wright AJ
Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
[TBL] [Abstract][Full Text] [Related]
22. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate.
Blom J; Löwbeer C; Elfström KM; Sventelius M; Öhman D; Saraste D; Törnberg S
J Med Screen; 2019 Jun; 26(2):92-97. PubMed ID: 30336730
[TBL] [Abstract][Full Text] [Related]
23. Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population.
Ramai D; Etienne D; Ayide G; Fields PJ; Reddy M
J Clin Gastroenterol; 2019; 53(10):744-749. PubMed ID: 30222644
[TBL] [Abstract][Full Text] [Related]
24. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
25. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
[TBL] [Abstract][Full Text] [Related]
26. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
27. Negative emotions and cancer fatalism are independently associated with uptake of Faecal Immunochemical Test-based colorectal cancer screening: Results from a population-based study.
Clarke N; Kearney PM; Gallagher P; McNamara D; O'Morain CA; Sharp L
Prev Med; 2021 Apr; 145():106430. PubMed ID: 33482227
[TBL] [Abstract][Full Text] [Related]
28. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.
Dillon M; Flander L; Buchanan DD; Macrae FA; Emery JD; Winship IM; Boussioutas A; Giles GG; Hopper JL; Jenkins MA; Ait Ouakrim D
PLoS Med; 2018 Aug; 15(8):e1002630. PubMed ID: 30114221
[TBL] [Abstract][Full Text] [Related]
29. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
[TBL] [Abstract][Full Text] [Related]
30. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
[TBL] [Abstract][Full Text] [Related]
31. Assessing knowledge and attitudes towards screening among users of Faecal Immunochemical Test (FIT).
Denters MJ; Deutekom M; Essink-Bot ML; Bossuyt PM; Fockens P; Dekker E
Health Expect; 2015 Oct; 18(5):839-49. PubMed ID: 23432931
[TBL] [Abstract][Full Text] [Related]
32. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.
Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z
J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822
[TBL] [Abstract][Full Text] [Related]
33. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
34. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
[No Abstract] [Full Text] [Related]
35. Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening.
Denters MJ; Deutekom M; Bossuyt PM; van Rijn AF; Fockens P; Dekker E
Cancer Epidemiol; 2013 Jun; 37(3):330-5. PubMed ID: 23403127
[TBL] [Abstract][Full Text] [Related]
36. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
37. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
38. Uptake trends in the Scottish Bowel Screening Programme and the influences of age, sex, and deprivation.
Quyn AJ; Fraser CG; Stanners G; Carey FA; Carden C; Shaukat A; Steele RJ
J Med Screen; 2018 Mar; 25(1):24-31. PubMed ID: 29183246
[TBL] [Abstract][Full Text] [Related]
39. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
Zorzi M; Fedeli U; Schievano E; Bovo E; Guzzinati S; Baracco S; Fedato C; Saugo M; Dei Tos AP
Gut; 2015 May; 64(5):784-90. PubMed ID: 25179811
[TBL] [Abstract][Full Text] [Related]
40. To participate or not? Giving voice to gender and socio-economic differences in colorectal cancer screening programmes.
Molina-Barceló A; Salas Trejo D; Peiró-Pérez R; Málaga López A
Eur J Cancer Care (Engl); 2011 Sep; 20(5):669-78. PubMed ID: 21771129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
